Martin H. Voss, MD, discusses recent advances in the treatment of advanced non–clear cell renal cell carcinoma and their impact on clinical practice.
EP. 2: Current Treatment Options for Non-Clear Cell Renal Cell Carcinoma
June 24th 2024A genitourinary oncologist discusses current treatment options available for patients with non–clear cell renal cell carcinoma and discusses the roles of tyrosine kinase inhibitors (TKIs), PD-1 inhibition, and combination therapy.
Watch